Amplefields Alternative Investments Ltd. – Trademark Portfolio

Entity Type: 99

Amplefields Alternative Investments Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include AMPLEFIELDS and AMPLEFIELDS ALTERNATIVE INVESTMENTS. The owner is based in Herzliya 4672552.

1 Ha-Menofim St

Herzliya 4672552 , IL

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Amplefields Alternative Investments Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Amplefields Alternative Investments Ltd. have?

Amplefields Alternative Investments Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Amplefields Alternative Investments Ltd. file in?

Amplefields Alternative Investments Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Amplefields Alternative Investments Ltd.'s most well-known trademarks?

Amplefields Alternative Investments Ltd.'s registered trademark portfolio includes well-known marks such as AMPLEFIELDS and AMPLEFIELDS ALTERNATIVE INVESTMENTS. These are among 2 currently registered trademarks in the portfolio.

What is Amplefields Alternative Investments Ltd.'s trademark registration success rate?

Amplefields Alternative Investments Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.